Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Humacyte (HUMA)

Annual Return

Over the past 3 years, HUMA has had an average annual return of -39.75%, underperforming the benchmark SPY, which returned +19.31% annual.

Since Aug 26, 2021, HUMA has had an average annual return of -43.69%, underperforming the benchmark SPY, which returned +12.48% annual.

202620252024202320222021
-31.62%-80.99%+77.85%+34.60%-70.90%-33.85%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+3.88%+11.76%-45.53%+38.63%+54.43%-39.97%-15.87%-31.62%
2025-9.31%-25.77%-49.84%-14.97%+84.13%-21.72%+14.84%-35.43%+12.31%-4.03%-19.16%-28.90%-80.99%
2024+16.90%+31.03%-28.50%+26.04%+90.80%-35.82%+97.05%-36.04%-10.07%-7.17%-10.50%+11.74%+77.85%
2023+24.68%+16.33%+0.97%+4.86%+5.89%-16.65%+14.72%+16.77%-23.52%-27.65%+25.03%+7.15%+34.60%
2022-25.79%+12.08%+17.08%+0.28%-23.31%-40.88%+8.40%+4.88%-10.69%+5.68%-9.42%-32.38%-70.90%
2021+33.39%-20.59%-21.62%+19.01%-33.05%-33.85%

Drawdown analysis of Humacyte (HUMA)

The maximum drawdown for the HUMA was -96.62%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The current HUMA drawdown is -96.14%.

Since Aug 26, 2021 HUMA has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-96.62%Sep 1, 20211147Mar 30, 2026OngoingOngoingOngoing